HCP
OCDX

Hexagon Capital Partners’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Hexagon Capital Partners’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23
Closed – – 1287
2022
Q1 		$0 Buy
+23
New +$414 ﹤0.01% 1007

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hexagon Capital Partners's OCDX Position: Q2 2022 in Review

Hexagon Capital Partners sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 23 shares.

Hexagon Capital Partners first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Hexagon Capital Partners reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Hexagon Capital Partners sold 23 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022.
  • Hexagon Capital Partners first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Hexagon Capital Partners's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $0 in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Hexagon Capital Partners's 13F filing for Q2 2022, filed 21 Jul 2022.